Phibro Animal Health sets date for optimistic 2026 results, highlighting stronger margins and growth prospects

Phibro Animal Health announced it will publish its fourth-quarter and full-year 2026 results on 26 August, amid signs of improved sales, profitability, and a robust balance sheet, signalling a promising outlook for the livestock and animal nutrition sector.

Phibro Animal Health has said it will publish fourth-quarter and full-year 2026 results on 26 August, after US markets close, before holding a conference call and webcast the next morning.

The Teaneck, New Jersey-based group said investors will be able to access slides and listen live via its investor relations site, with telephone access also available for participants in North America and overseas. A replay is due to be posted about two hours after the call ends.

The announcement follows a series of guidance updates this year in which Phibro lifted its fiscal 2026 outlook, citing stronger sales and profitability trends. In its most recent trading update, the company projected net sales of up to $1.5bn, compared with earlier expectations in the same range, while net income and adjusted earnings were also forecast to rise sharply. Phibro also said in April that it had increased the size of its revolving credit facility, giving it more borrowing headroom.

The company, which supplies animal health and mineral nutrition products to livestock and companion-animal markets, will use next week’s call to give investors a final read-through on a year that has so far shown improving margins and a stronger balance sheet.